⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 38 in last 7 days 🍎 Food: 116 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 38 in last 7 days 🍎 Food: 116 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 5, 2026

Enantone Monats-Depot - Zweikammerspritze (Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension)

📷 Wikipedia: Leuprorelin · Source
Enantone Monats-Depot - Zweikammerspritze (Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension)
📷 Wikipedia: Leuprorelin · Source
Parallel export ban in effect.
⚠️
Shortage ongoing
LEUPRORELIN ACETAT is currently in short supply in AT.
📈 Timeline
2 days active so far
June 9, 2026 June 10, 2026

What is this? Enantone Monats-Depot is a medicine used in injections. It comes as a powder and liquid that are mixed before use.

What's happening? There is not enough of this medicine in Austria right now. Only limited packs are available.

Does this affect me? If you use this medicine in Austria, you may have trouble getting it.

What should I do? Ask your pharmacist or doctor for advice before running out.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
LEUPRORELIN ACETAT
Agency-published detail

🚫 Parallel export ban active · ATC: L02AE02 · Reason: Unzureichendes Kontingent für Österreich · Marketing authorisation holder: Takeda Pharma Ges.m.b.H., Gebäude F Technologiestraße 5, 1120 Wien, Österreich · Affected packs: 1 Stück Schachtel, Fertigspritze, Fertigspritze [eingeschränkt verfügbar, since 2026-06-05]

First published
June 5, 2026
Last refreshed by us
1 hour ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Low AT 5 days ago

Enantone-Gyn Monats-Depot - Zweikammerspritze (Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension)

Enantone-Gyn Monthly Depot - two-chamber syringe (powder and solvent for injection suspension) Parallel export ban in effect.
Low AT 5 days ago

Trenantone - Zweikammerspritze (Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension)

Parallel export ban in effect.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Enantone Monats-Depot - Zweikammerspritze (Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension). Parallel export ban in effect.
▸ When was this alert issued?
This alert was issued on June 5, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.